News

Gene plays key role in iron homeostasis


 

Red blood cells

A gene known to prevent autoimmune diseases is a key regulator in iron uptake, according to research published in Cell Reports.

“We found previously that, when mice lack the gene Regnase-1, they suffer from severe autoimmune diseases and anemia,” said study author Masanori Yoshinaga, MD, of Kyoto University in Japan.

“At first, we assumed that anemia was a secondary effect, but, after detailed analysis, we found that the 2 symptoms develop independently.”

Continued study of mice with a Regnase-1 mutation revealed a functional defect in the principal site for iron absorption in the body, the duodenum.

“The next step was to find the role of Regnase-1 in iron-uptake maintenance,” Dr Yoshinaga said. “We started by looking at the most important iron-uptake gene, Transferrin Receptor 1, or TfR1.”

“Our results showed that Regnase-1 degrades the mRNA of TfR1, thereby inhibiting the synthesis of the TfR1 protein and, additionally, that it likely regulates other important iron-controlling genes.”

“Further analysis of Regnase-1 in iron-related homeostasis may provide insight into the mechanisms causing anemia and other iron-related disorders, perhaps eventually leading to new methods of treatment,” said study author Osamu Takeuchi, MD, PhD, of Kyoto University.

Recommended Reading

PPIs triple heart failure hospitalization risk in atrial fib patients
MDedge Hematology and Oncology
Oral iron of no benefit in heart failure with iron deficiency
MDedge Hematology and Oncology
FDA advisory committee supports L-glutamine for SCD
MDedge Hematology and Oncology
FDA panel backs licensure for epoetin alfa biosimilar
MDedge Hematology and Oncology
Authority on hematologic malignancies dies
MDedge Hematology and Oncology
FDA approves new formulation of deferasirox
MDedge Hematology and Oncology
Severe hospital-acquired anemia linked to readmission, death
MDedge Hematology and Oncology
Drug receives rare pediatric disease designation for SCD
MDedge Hematology and Oncology
Iron-transporting molecule could treat anemia, iron overload
MDedge Hematology and Oncology
EMA recommends drug receive orphan designation for PNH
MDedge Hematology and Oncology